Mendus Announces Nomination Committee for the 2025 Annual General Meeting

What we doOur approachPipelineTechnologyPublications
About usExecutive ManagementBoard of DirectorsScientific Advisory Board
News & eventsPress releasesEventsInterviews
Investors
Careers

Back
Mendus Announces Nomination Committee for the 2025 Annual General Meeting
 1:00:00 PM

Keep reading
Updated data from the ADVANCE II Phase 2 trial presented at ASH demonstrate durable survival of AML patients treated with vididencelRead